Total Payments
$2,318
2024 Payments
$18.33
Companies
4
Transactions
14
Medicare Patients
10,530
Medicare Billing
$600,621
Payment Breakdown by Category
Other$2,120 (91.5%)
Food & Beverage$175.07 (7.6%)
Education$22.65 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,120 | 1 | 91.5% |
| Food and Beverage | $175.07 | 9 | 7.6% |
| Education | $22.65 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $2,120 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $96.17 | 5 | $0 (2018) |
| LANTHEUS MEDICAL IMAGING, INC. | $65.03 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $36.52 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.33 | 1 | LANTHEUS MEDICAL IMAGING, INC. ($18.33) |
| 2022 | $17.49 | 1 | Merck Sharp & Dohme LLC ($17.49) |
| 2021 | $19.03 | 1 | Merck Sharp & Dohme Corporation ($19.03) |
| 2018 | $2,207 | 8 | Philips Electronics North America Corporation ($2,120) |
| 2017 | $55.87 | 3 | Novartis Pharmaceuticals Corporation ($55.87) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CONTRAST AGENT | ||||||
| 07/21/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2018 | Philips Electronics North America Corporation | PCMS Und (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,120.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2018 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Education | In-kind items and services | $8.32 | General |
| Category: Contrast Agent | ||||||
| 09/25/2018 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Education | In-kind items and services | $7.53 | General |
| Category: Contrast Agent | ||||||
| 08/22/2018 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Education | In-kind items and services | $3.40 | General |
| Category: Contrast Agent | ||||||
| 07/30/2018 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Education | In-kind items and services | $3.40 | General |
| Category: Contrast Agent | ||||||
| 05/04/2018 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Contrast Agent | ||||||
| 03/02/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/30/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/28/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,854 | 2,398 | $543,574 | $123,231 |
| 2022 | 27 | 2,784 | 3,832 | $777,880 | $150,688 |
| 2021 | 29 | 3,147 | 4,675 | $918,020 | $177,606 |
| 2020 | 25 | 2,745 | 4,059 | $634,060 | $149,097 |
Total Patients
10,530
Total Services
14,964
Medicare Billing
$600,621
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 162 | 256 | $117,652 | $27,638 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 196 | 282 | $96,624 | $19,097 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 99 | 104 | $59,170 | $15,972 | 27.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 64 | $29,870 | $8,604 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 51 | $23,420 | $7,098 | 30.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 138 | 138 | $30,805 | $6,989 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 61 | $20,984 | $5,442 | 25.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 41 | $10,660 | $3,921 | 36.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 64 | 64 | $20,864 | $3,605 | 17.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 432 | 533 | $23,985 | $3,009 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $16,181 | $2,955 | 18.3% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 32 | 68 | $13,600 | $2,417 | 17.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $8,280 | $2,403 | 29.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 11 | 11 | $9,390 | $2,115 | 22.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 27 | 69 | $5,520 | $1,445 | 26.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 25 | 25 | $7,250 | $1,346 | 18.6% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 16 | 41 | $6,560 | $1,081 | 16.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 92 | 93 | $14,415 | $962.34 | 6.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 17 | $3,060 | $957.40 | 31.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 11 | 47 | $3,055 | $878.64 | 28.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 103 | $2,060 | $865.20 | 42.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Facility | 2023 | 12 | 48 | $3,120 | $846.24 | 27.1% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 24 | 25 | $3,750 | $744.00 | 19.8% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 16 | 17 | $2,010 | $506.94 | 25.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 45 | $2,475 | $473.20 | 19.1% |
About Dr. Borzoo Nikpoor, MD
Dr. Borzoo Nikpoor, MD is a Cardiovascular Disease healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053586487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Borzoo Nikpoor, MD has received a total of $2,318 in payments from pharmaceutical and medical device companies, with $18.33 received in 2024. These payments were reported across 14 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,120).
As a Medicare-enrolled provider, Nikpoor has provided services to 10,530 Medicare beneficiaries, totaling 14,964 services with total Medicare billing of $600,621. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brockton, MA
- Active Since 04/27/2008
- Last Updated 07/21/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1053586487
Products in Payments
- PCMS Und (Device) $2,120
- ENTRESTO (Drug) $96.17
- Definity (Drug) $46.70
- VERQUVO (Drug) $36.52
- DEFINITY (Drug) $18.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brockton
Sumon Roy, Md, MD
Cardiovascular Disease — Payments: $37,482
Cardiovascular Disease $37,482
Bruce Kriegel, Md, MD
Cardiovascular Disease — Payments: $13,668
Cardiovascular Disease $13,668
Gary Miller, M.d, M.D
Cardiovascular Disease — Payments: $13,649
Cardiovascular Disease $13,649
Benoy Zachariah, Md, MD
Cardiovascular Disease — Payments: $8,683
Cardiovascular Disease $8,683
Barry Arkin, Md, MD
Cardiovascular Disease — Payments: $6,742
Cardiovascular Disease $6,742
Syed Tahir, Md, MD
Cardiovascular Disease — Payments: $5,461
Cardiovascular Disease $5,461